Volume 86, Issue 5, Pages (November 2014)

Slides:



Advertisements
Similar presentations
The Scribner shunt: 50 years later
Advertisements

Propofol-related green urine
Volume 82, Issue 1, Pages 7-8 (July 2012)
Viper venom for diabetic nephropathy
Volume 79, Issue 6, Pages (March 2011)
C-reactive protein and dialysis access
Membranous nephropathy: When and how to treat
Viper venom for diabetic nephropathy
Volume 93, Issue 1, Pages (January 2018)
Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)
Volume 80, Issue 10, Pages (November 2011)
Peter Rossing, Philip Hougaard, Hans-Henrik Parving 
C-reactive protein and dialysis access
Ho-Han Wu, Szu-Yuan Li, Wu-Chang Yang  Kidney International 
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 80, Issue 9, Pages (November 2011)
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell 
The need for reliable serum parathyroid hormone measurements
Nephrology Crosswords: Hemodialysis
The epidemiology of chronic kidney disease
Volume 87, Issue 2, Pages (February 2015)
Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor.
Nephrology Crossword: History of nephrology
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Volume 61, Issue 4, Pages (April 2002)
David M. Charytan, John P. Forman  Kidney International 
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver- derived angiotensinogen  David I. Ortiz-Melo, Robert F. Spurney 
A physician's perseverance uncovers problems in a key nephrology study
Volume 53, Issue 4, Pages (April 1998)
Volume 82, Issue 3, Pages (August 2012)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 8, Pages (October 2008)
Nephrology Crossword: Peritoneal Dialysis
The kidney, a cardiovascular risk marker, and a new target for therapy
Extracorporeal removal of toxins
Nephrology Crossword: Glomerulonephritis
Volume 80, Issue 3, Pages (August 2011)
A man with a hole in his penis
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
The treatment of acute interstitial nephritis: More data at last
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
The course of the remnant kidney model in mice
Volume 73, Issue 5, Pages (March 2008)
Organ transplantation goes to the movies
David Z. Levine, M.D., Michelle Iacovitti, Kevin D. Burns, Amy Slater 
Volume 83, Issue 5, Pages (May 2013)
Volume 68, Issue 5, Pages (November 2005)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 68, Pages S98-S102 (December 2005)
Volume 64, Issue 4, Pages (October 2003)
Volume 74, Issue 9, Pages (November 2008)
Does an apple a day put hypertension in play?
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
Volume 62, Issue 5, (November 2002)
Innovative teaching tools in nephrology
Angiotensin I-Converting Enzyme
Volume 58, Issue 6, Pages (December 2000)
The international realities of live donor kidney transplantation
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Friends, social networks, and progressive chronic kidney disease
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Proteinuria and hypertension with tyrosine kinase inhibitors
Presentation transcript:

Volume 86, Issue 5, Pages 1057-1058 (November 2014) Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes  David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou, Fengxia Xiao, Joseph Zimpelmann, Hans-Juergen Woerle, Odd E Johansen, Uli C. Broedl, Maximilian von Eynatten, Kevin D. Burns  Kidney International  Volume 86, Issue 5, Pages 1057-1058 (November 2014) DOI: 10.1038/ki.2014.246 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Urinary ACE2 protein and activity, and angiotensinogen and ACE levels during clamped euglycemia and hyperglycemia before and after treatment with empagliflozin for 8 weeks. (a) *P<0.05 vs. baseline euglycemia. †P<0.05 vs. baseline hyperglycemia. (b) *P<0.05 vs. baseline euglycemia. †P<0.05 vs. baseline hyperglycemia. (c) *P<0.05 vs. baseline euglycemia. (d) *P<0.05 vs. baseline euglycemia. †P<0.05 vs. baseline hyperglycemia. ACE, angiotensin-converting. enzyme; ELISA, enzyme-linked immunosorbent assay. Kidney International 2014 86, 1057-1058DOI: (10.1038/ki.2014.246) Copyright © 2014 International Society of Nephrology Terms and Conditions